Cost-effectiveness of umeclidinium compared with tiotropium and glycopyrronium as monotherapy for chronic obstructive pulmonary disease: a UK perspective

Overview of attention for article published in Cost Effectiveness and Resource Allocation, May 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

blogs: 1 blog

twitter: 1 X user

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 28 Mendeley

Summary Blogs X Dimensions citations

So far, Dimensions has found 4 publications that cite this research output.

4

The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.

Economic evaluations of chronic obstructive pulmonary disease pharmacotherapy: how well are the real-world issues of medication adherence, comorbidities and adverse drug-reactions addressed?

Article in Expert Opinion on Pharmacotherapy (January 2021)

Cost-Effectiveness Analysis of a Once-Daily Single-Inhaler Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease (COPD) Using the FULFIL Trial: A Spanish Perspective

Article in International Journal of Chronic Obstructive Pulmonary Disease (July 2020)

Novedades en la clasificación, diagnóstico y tratamiento de la EPOC

Article in FMC - Formación Médica Continuada en Atención Primaria (December 2019)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.